Patil, V., Joshi, A., Noronha, V., Agarwala, V., Chougule, A., Kanan, S., . . . Prabhash, K. (2019). Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer. Oncotarget.
Citação norma ChicagoPatil, Vijay, et al. "Randomized Phase 3 Open Label Study of Quality of Life of Patients On Pemetrexed Versus Erlotinib As Maintenance Therapy for Advanced Non Squamous Non EGFR Mutated Non Small Cell Lung Cancer." Oncotarget 2019.
ציטוט MLAPatil, Vijay, et al. "Randomized Phase 3 Open Label Study of Quality of Life of Patients On Pemetrexed Versus Erlotinib As Maintenance Therapy for Advanced Non Squamous Non EGFR Mutated Non Small Cell Lung Cancer." Oncotarget 2019.